Loading clinical trials...
Loading clinical trials...
Phase 2 Study of Autologous Hematopoietic Cell Transplantation for Core-binding Factor Positive Acute Myeloid Leukemia in the First Complete Remission
Conditions
Interventions
autologous hematopoietic cell transplantation
Locations
11
South Korea
Wonkwang University Hospital
Iksan, Chollabuk-do, South Korea
Gyeongsang National University Hospital
Jinju, Gyeongsangnam-do, South Korea
Hallym University Sacred Heart Hospital
Anyang, Kyeongki-do, South Korea
Kosin University, Gospel Hospital
Busan, South Korea
Busan Paik Hospital, Inje University College of Medicine
Busan, South Korea
Daegu Fatima Hospital
Daegu, South Korea
Start Date
January 11, 2010
Primary Completion Date
October 30, 2018
Completion Date
October 30, 2018
Last Updated
March 17, 2025
NCT06852222
NCT06580106
NCT06501196
NCT06384261
NCT06382168
NCT06537726
Lead Sponsor
Asan Medical Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions